Srinivas Akkaraju - Mar 18, 2025 Form 3/A - Amendment Insider Report for Kalaris Therapeutics, Inc. (KLRS)

Role: Director, 10%+ Owner
Signature: /s/ Andrew Oxtoby, Attorney-in-Fact
Stock symbol: KLRS
Transactions as of: Mar 18, 2025
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 3/26/2025, 05:06 PM
Date Of Original Report: Mar 18, 2025
Previous filing: Mar 17, 2025
Next filing: Apr 11, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	KLRS	Common Stock						3.58K	Mar 18, 2025	See Footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were omitted from the reporting person's original Form 3, and also were omitted from the Form 4 filed by the reporting person on March 18, 2025.
F2	Shares held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.

Content

These shares were omitted from the reporting person's original Form 3, and also were omitted from the Form 4 filed by the reporting person on March 18, 2025.

Shares held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.